Učitavanje...
Semaglutide for the Treatment of Type 2 Diabetes Mellitus
Objective: To detail studies investigating the efficacy/safety of semaglutide as a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the treatment of type 2 diabetes mellitus. Data Sources: A literature search in MEDLINE and ClinicalTrials.gov (January 2013 to May 2018) using the terms semaglut...
Spremljeno u:
| Izdano u: | J Pharm Technol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6231279/ https://ncbi.nlm.nih.gov/pubmed/34861016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122518790925 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|